Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Pfizer Inc.

Report proof-of-concept readouts for PF-06939926

Delivered by the deadline

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced
28 Jan 2020
Due
30 Jun 2020
Delivered
May 2020
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“proof-of-concept readouts for PF-06939926, our mini-dystrophin gene therapy candidate for Duchenne muscular dystrophy”
  • SourcePfizer Inc. Form 8-K press release, 2020-01-28
  • FilingSEC filing index
  • Deadline as statedfirst half of 2020
  • Deadline used30 Jun 2020, the last day of the stated period
  • TypeProduct
  • Permanent referenceKI-C-2020-PFE-001734
    Cite as https://keptindex.org/c/KI-C-2020-PFE-001734/ — this address never changes.

What we found

Evidence strength A What the grades mean

Pfizer announced updated Phase 1b clinical data for PF-06939926 in May 2020, which falls within the first half of 2020 deadline.

  • A
    Pfizer Inc. 8-K filed 2020-07-28 Regulatory filing · published 28 Jul 2020 · retrieved 1 Oct 2026 · kept permanently by the SEC · fingerprint c51118da0877
    “In May 2020, Pfizer announced updated Phase 1b clinical data on PF-06939926, an investigational gene therapy being developed to treat DMD.” ✓ confirmed on the page

Market reaction: the shares moved +4.0% against the S&P 500 over the three sessions around the disclosure (27 Jul 2020 to 30 Jul 2020). What this measures

Checked 1 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Clinical readout
Indicative materiality
Medium rules
Action
Report
Deliverable
PF-06939926 proof-of-concept results
In the company’s control
High
Specificity
High

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you Pfizer Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2020-PFE-001734 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.